CoChat

MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors

Open access

Published version of a preprint

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Cancer is a hyper-proliferative disease. Whether the proliferative state originates from the cell-of-origin or emerges later remains difficult to resolve. By tracking de novo transformation from normal hematopoietic progenitors expressing an acute myeloid leukemia (AML) oncogene MLL-AF9, we reveal that the cell cycle rate heterogeneity among granulocyte–macrophage progenitors (GMPs) determines their probability of transformation. A fast cell cycle intrinsic to these progenitors provide permissiveness for transformation, with the fastest cycling 3% GMPs acquiring malignancy with near certainty. Molecularly, we propose that MLL-AF9 preserves gene expression of the cellular states in which it is expressed. As such, when expressed in the naturally-existing, rapidly-cycling immature myeloid progenitors, this cell state becomes perpetuated, yielding malignancy. In humans, high CCND1 expression predicts worse prognosis for MLL fusion AMLs. Our work elucidates one of the earliest steps toward malignancy and suggests that modifying the cycling state of the cell-of-origin could be a preventative approach against malignancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-13666-5

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Tracking MLL-AF9-mediated transformation from single hematopoietic cells. a Schema of the inducible MLL-AF9-IRES-ΔNGFR allele targeted into the endogenous Hprt locus. b Dox-dependent serial colony formation by iMLL-AF9 GMPs; n = 3 for both conditions, p < 0.001 for all comparisons. c Kaplan–Meier curve of cohorts of mice transplanted with 12,000 iMLL-AF9 GMPs, fed with control or Dox water (n = 6 for each group). AML pathology was confirmed and shown in Supplementary Fig. 2a–d. p = 0.0008 as calculated by log-rank (Mantel–Cox) test. d Representative images tracking single GMPs and their progeny in micro-wells. Cells in micro-wells were kept in liquid culture for 2 days, after which the medium was replaced by methylcellulose (MethoCult GF M3434) to allow colony formation. The presence of colonies was verified after another 5 days (for a total of 7 days in culture). Scale bars represent 500 μm for upper panels, and 100 μm for lower panels. e Comparison of iMLL-AF9 GMP proliferation rates in micro-wells and in bulk culture. The proliferation rates in micro-wells were calculated by adding up all cell numbers from individual wells, n = 3 for micro-well culture; n = 2 for bulk culture. f Colony forming efficiencies from single iMLL-AF9 GMPs following the schema in d. The presence of single cells was confirmed at day 0; n = 4 for −Dox, n = 3 for + Dox, p = 0.0012. g Single colonies, as shown in d, were plucked and replated in methylcellulose for secondary colony formation. The percentages of colonies that gave rise to replatable colonies are plotted. None of the 30 colonies formed in the absence of Dox supported replating, while 74 of the 86 colonies formed in the presence of Dox supported replating. h RT-QPCR analyses of Hoxa9 and Meis1 in colonies formed by single iMLL-AF9 GMPs +/−Dox; n = 3, p = 0.002 for Hoxa9, p < 0,001 for Meis1. Results are presented as mean±s.d. p values (except for Kaplan–Meier curve) were calculated by two-sided unpaired t-test.
Fig. 1 Tracking MLL-AF9-mediated transformation from single hematopoietic cells. a Schema of the inducible MLL-AF9-IRES-ΔNGFR allele targeted into the endogenous Hprt locus. b Dox-dependent serial colony formation by iMLL-AF9 GMPs; n = 3 for both conditions, p < 0.001 for all comparisons. c Kaplan–Meier curve of cohorts of mice transplanted with 12,000 iMLL-AF9 GMPs, fed with control or Dox water (n = 6 for each group). AML pathology was confirmed and shown in Supplementary Fig. 2a–d. p = 0.0008 as calculated by log-rank (Mantel–Cox) test. d Representative images tracking single GMPs and their progeny in micro-wells. Cells in micro-wells were kept in liquid culture for 2 days, after which the medium was replaced by methylcellulose (MethoCult GF M3434) to allow colony formation. The presence of colonies was verified after another 5 days (for a total of 7 days in culture). Scale bars represent 500 μm for upper panels, and 100 μm for lower panels. e Comparison of iMLL-AF9 GMP proliferation rates in micro-wells and in bulk culture. The proliferation rates in micro-wells were calculated by adding up all cell numbers from individual wells, n = 3 for micro-well culture; n = 2 for bulk culture. f Colony forming efficiencies from single iMLL-AF9 GMPs following the schema in d. The presence of single cells was confirmed at day 0; n = 4 for −Dox, n = 3 for + Dox, p = 0.0012. g Single colonies, as shown in d, were plucked and replated in methylcellulose for secondary colony formation. The percentages of colonies that gave rise to replatable colonies are plotted. None of the 30 colonies formed in the absence of Dox supported replating, while 74 of the 86 colonies formed in the presence of Dox supported replating. h RT-QPCR analyses of Hoxa9 and Meis1 in colonies formed by single iMLL-AF9 GMPs +/−Dox; n = 3, p = 0.002 for Hoxa9, p < 0,001 for Meis1. Results are presented as mean±s.d. p values (except for Kaplan–Meier curve) were calculated by two-sided unpaired t-test.CC BY · PubMed Central
Fig. 2 MLL-AF9-mediated transformation efficiency is associated with the intrinsic cycling rate of GMPs. a, b Cell cycle rates of individual iMLL-AF9 GMP lineages. The presence of single GMP was confirmed at 0 h, and plotted as individual dots. a −Dox: n = 268; b +Dox: n = 378 (Dox was added at 0 h). The number of divisions during 0–24 h (x-axis) = Log2(cell number at 24 h/cell number at 0 h); the number of divisions during 24–48 h (y-axis) = Log2(cell number at 48 h/cell number at 24 h). Pseudo color denotes GMP lineage density, with the highest observed density in each sample normalized to 100. Dotted diagonal line denotes y = x. In the presence of Dox, significant number of GMP lineages underwent cell cycle acceleration, shown as the dense population above the diagonal line. c Cell cycle rate distribution during 0–24 h of iMLL-AF9 GMP culture +/−Dox. Cell cycle rates were determined as described in a, b, and rounded up to the nearest integer. Detailed measurements are shown in Supplementary Table 1; n = 3 for +/−Dox measurements. No significant difference was observed between +/−Dox conditions. d Similar analysis as in c performed for 24–48 h of culture; n = 3 for +/−Dox measurements. p = 0.0036 for two divisions, as calculated by unpaired t-test. e Single-cell colony-forming efficiency by iMLL-AF9 GMPs of different cycling rates as defined by number of cell divisions during 0–24 h in vitro culture. Dotted lines represent linear regressions; n = 3 for +/−Dox. For + Dox condition, y = 28.06 × −0.4914, p < 0.0001; for −Dox condition, y = 0.08382 × + 1.778, p = 0.9466. f Schematic timeline for measuring colony-forming efficiencies in relation to cell cycle rates before and after Dox addition. Orange bars denote the time before Dox addition and the red bars denote the time after Dox addition. g Single-cell colony-forming efficiency in iMLL-AF9 GMPs of different cycling rates prior to Dox induction, as shown in orange in f; n = 2. Dotted line represents linear regression: y = 7.140 × + 4.852, p = 0.1998. h Single-cell colony-forming efficiency in iMLL-AF9 GMPs of different cycling rates following Dox induction, as shown in red in f; n = 2. Dotted line represents linear regression: y = 21.47 × −7.473, p = 0.0016. Results are presented as mean±s.d. p value for linear regression was calculated by F-test to assess whether the slope is significantly nonzero.
Fig. 2 MLL-AF9-mediated transformation efficiency is associated with the intrinsic cycling rate of GMPs. a, b Cell cycle rates of individual iMLL-AF9 GMP lineages. The presence of single GMP was confirmed at 0 h, and plotted as individual dots. a −Dox: n = 268; b +Dox: n = 378 (Dox was added at 0 h). The number of divisions during 0–24 h (x-axis) = Log2(cell number at 24 h/cell number at 0 h); the number of divisions during 24–48 h (y-axis) = Log2(cell number at 48 h/cell number at 24 h). Pseudo color denotes GMP lineage density, with the highest observed density in each sample normalized to 100. Dotted diagonal line denotes y = x. In the presence of Dox, significant number of GMP lineages underwent cell cycle acceleration, shown as the dense population above the diagonal line. c Cell cycle rate distribution during 0–24 h of iMLL-AF9 GMP culture +/−Dox. Cell cycle rates were determined as described in a, b, and rounded up to the nearest integer. Detailed measurements are shown in Supplementary Table 1; n = 3 for +/−Dox measurements. No significant difference was observed between +/−Dox conditions. d Similar analysis as in c performed for 24–48 h of culture; n = 3 for +/−Dox measurements. p = 0.0036 for two divisions, as calculated by unpaired t-test. e Single-cell colony-forming efficiency by iMLL-AF9 GMPs of different cycling rates as defined by number of cell divisions during 0–24 h in vitro culture. Dotted lines represent linear regressions; n = 3 for +/−Dox. For + Dox condition, y = 28.06 × −0.4914, p < 0.0001; for −Dox condition, y = 0.08382 × + 1.778, p = 0.9466. f Schematic timeline for measuring colony-forming efficiencies in relation to cell cycle rates before and after Dox addition. Orange bars denote the time before Dox addition and the red bars denote the time after Dox addition. g Single-cell colony-forming efficiency in iMLL-AF9 GMPs of different cycling rates prior to Dox induction, as shown in orange in f; n = 2. Dotted line represents linear regression: y = 7.140 × + 4.852, p = 0.1998. h Single-cell colony-forming efficiency in iMLL-AF9 GMPs of different cycling rates following Dox induction, as shown in red in f; n = 2. Dotted line represents linear regression: y = 21.47 × −7.473, p = 0.0016. Results are presented as mean±s.d. p value for linear regression was calculated by F-test to assess whether the slope is significantly nonzero.CC BY · PubMed Central
Fig. 3 MLL-AF9 expression sustains the already existing gene expression program in GMPs. a The expression levels of Hoxa9 and Meis1 in LKS, fresh GMPs, and GMPs cultured +/−Dox. The fold of change in each gene expression relative to the levels in fresh GMPs are shown. p < 0.01 for all pair-wise comparisons as calculated by two-sided unpaired t-test. b Expression levels of Acod1 and Cxcl2 in fresh GMPs and GMPs cultured +/–Dox. c Scatter plot showing culture-induced gene expression changes (−Dox vs fresh GMPs) vs MLL-AF9-induced changes (+Dox vs −Dox GMPs). Blue dots represent the oncogene downregulated DEGs; red dots represent the oncogene upregulated DEGs. d Cumulative distribution function plot showing the expression levels of DEGs in fresh GMPs. DEGs are derived by comparing +/−Dox GMPs. Red line: genes upregulated in +Dox GMPs (n = 1258); blue line: genes downregulated in +Dox GMPs (n = 1715). TPM: transcript per million. p < 0.0001 from Kolmogorov–Smirnov test. e Representative expression levels of up/downregulated cell cycle genes. f Meta plot summarizing the intensities of up/down ATAC-seq peaks in fresh GMPs. The up and down ATAC-seq peaks are defined by comparing +Dox GMPs vs −Dox GMPs. g Dox inductions (red line) prevented the opening of chromatin regions during GMP culture (left, blue vs black lines), and promoted the further opening of chromatin regions that are already accessible in fresh GMPs (right, blue line). The ATAC-seq peaks (down or up) are defined by comparing +Dox GMPs vs −Dox GMPs. h The direct targets of MLL-AF9 (red line, defined by MLL-AF9 ChIP-Seq24) were highly accessible in fresh GMPs, beyond those more accessible regions caused by Dox induction (cyan line). i 24 h of Dox induction (red line) promoted further opening of the genomic regions directly bound by MLL-AF9 (defined by MLL-AF9 CHIP-Seq24), which display significant accessibility in fresh GMPs (blue line). Results are presented as mean±s.d.
Fig. 3 MLL-AF9 expression sustains the already existing gene expression program in GMPs. a The expression levels of Hoxa9 and Meis1 in LKS, fresh GMPs, and GMPs cultured +/−Dox. The fold of change in each gene expression relative to the levels in fresh GMPs are shown. p < 0.01 for all pair-wise comparisons as calculated by two-sided unpaired t-test. b Expression levels of Acod1 and Cxcl2 in fresh GMPs and GMPs cultured +/–Dox. c Scatter plot showing culture-induced gene expression changes (−Dox vs fresh GMPs) vs MLL-AF9-induced changes (+Dox vs −Dox GMPs). Blue dots represent the oncogene downregulated DEGs; red dots represent the oncogene upregulated DEGs. d Cumulative distribution function plot showing the expression levels of DEGs in fresh GMPs. DEGs are derived by comparing +/−Dox GMPs. Red line: genes upregulated in +Dox GMPs (n = 1258); blue line: genes downregulated in +Dox GMPs (n = 1715). TPM: transcript per million. p < 0.0001 from Kolmogorov–Smirnov test. e Representative expression levels of up/downregulated cell cycle genes. f Meta plot summarizing the intensities of up/down ATAC-seq peaks in fresh GMPs. The up and down ATAC-seq peaks are defined by comparing +Dox GMPs vs −Dox GMPs. g Dox inductions (red line) prevented the opening of chromatin regions during GMP culture (left, blue vs black lines), and promoted the further opening of chromatin regions that are already accessible in fresh GMPs (right, blue line). The ATAC-seq peaks (down or up) are defined by comparing +Dox GMPs vs −Dox GMPs. h The direct targets of MLL-AF9 (red line, defined by MLL-AF9 ChIP-Seq24) were highly accessible in fresh GMPs, beyond those more accessible regions caused by Dox induction (cyan line). i 24 h of Dox induction (red line) promoted further opening of the genomic regions directly bound by MLL-AF9 (defined by MLL-AF9 CHIP-Seq24), which display significant accessibility in fresh GMPs (blue line). Results are presented as mean±s.d.CC BY · PubMed Central
Fig. 4 MLL-AF9 preserves the heterogeneous gene expression states as analyzed by scRNA-seq. a Swarm plots showing the expression levels of Hoxa9, Meis1, and Mef2c in cultured GMPs in the presence or absence of Dox. White dots indicate mean of each sample. b PHATE plot of cultured GMPs in the presence (pink dots) or absence of Dox (purple dots). c Pseudocolor denoting enhanced experimental signal (EES) is overplayed on the PHATE plot. EES is derived by comparing the GMPs cultured in the presence or absence of Dox, where a larger EES score indicates more enrichment in the +Dox GMPs. d Based on their gene expression similarity, five clusters of cells were determined. Their positions on the PHATE plot are shown. e EES of individual cells within each cluster. f Expression levels of Cdk4 and Cdk6 in each GMP cluster. g Expression levels of Hoxa9, Meis1, and Mef2c in each GMP cluster. The values for cells cultured in the absence or presence of Dox were plotted separately.
Fig. 4 MLL-AF9 preserves the heterogeneous gene expression states as analyzed by scRNA-seq. a Swarm plots showing the expression levels of Hoxa9, Meis1, and Mef2c in cultured GMPs in the presence or absence of Dox. White dots indicate mean of each sample. b PHATE plot of cultured GMPs in the presence (pink dots) or absence of Dox (purple dots). c Pseudocolor denoting enhanced experimental signal (EES) is overplayed on the PHATE plot. EES is derived by comparing the GMPs cultured in the presence or absence of Dox, where a larger EES score indicates more enrichment in the +Dox GMPs. d Based on their gene expression similarity, five clusters of cells were determined. Their positions on the PHATE plot are shown. e EES of individual cells within each cluster. f Expression levels of Cdk4 and Cdk6 in each GMP cluster. g Expression levels of Hoxa9, Meis1, and Mef2c in each GMP cluster. The values for cells cultured in the absence or presence of Dox were plotted separately.CC BY · PubMed Central
Fig. 5 The primary gene expression changes in response to MLL-AF9 induction is cell context dependent. a Workflow showing iMLL-AF9 LKS, GMP, or Mac1+ cells after their isolation on day 0 (fresh), or treated +/−Dox for 2 days. b Proliferation rates of respective cell types during 2 days of culture +/−Dox; n = 2, error bars represent s.d. c Venn diagram showing little overlap among up/downregulated DEGs from LKS, GMP, and Mac1+cells. Cell type-specific DEGs (p < 0.05) were defined between the respective cells treated +/−Dox. d Scatter plot showing culture-induced gene expression changes (−Dox vs fresh) vs MLL-AF9-induced changes (+Dox vs −Dox) in three cell types. Blue dots represent the oncogene downregulated DEGs; red dots represent the oncogene upregulated DEGs. e The Dox-induced DEGs, similar to those defined in c but at p < 0.01, were queried against the gene expression changes occurred during culture in the respective cell types by GSEA. For GMPs, only the top 200 DEGs were used.
Fig. 5 The primary gene expression changes in response to MLL-AF9 induction is cell context dependent. a Workflow showing iMLL-AF9 LKS, GMP, or Mac1+ cells after their isolation on day 0 (fresh), or treated +/−Dox for 2 days. b Proliferation rates of respective cell types during 2 days of culture +/−Dox; n = 2, error bars represent s.d. c Venn diagram showing little overlap among up/downregulated DEGs from LKS, GMP, and Mac1+cells. Cell type-specific DEGs (p < 0.05) were defined between the respective cells treated +/−Dox. d Scatter plot showing culture-induced gene expression changes (−Dox vs fresh) vs MLL-AF9-induced changes (+Dox vs −Dox) in three cell types. Blue dots represent the oncogene downregulated DEGs; red dots represent the oncogene upregulated DEGs. e The Dox-induced DEGs, similar to those defined in c but at p < 0.01, were queried against the gene expression changes occurred during culture in the respective cell types by GSEA. For GMPs, only the top 200 DEGs were used.CC BY · PubMed Central
Fig. 6 Modification of the initial cell state by cell cycle inhibition mitigates MLL-AF9-mediated transformation. a Schematics illustrating the transformed colony formation by iMLL-AF9 GMPs +/−Pal. b Single-cell colony-forming assay showing colony forming efficiencies from iMLL-AF9 GMPs transiently treated with palbociclib. Each pair of dots connected by the line represent colony forming efficiencies of GMPs from a different iMLL-AF9 mouse; (n = 3), p = 0.0221 by paired t-test. c, d Quantification of colony number c and size d of bulk cultured iMLL-AF9 GMPs in methylcellulose +/−Pal. Dox was added to all conditions. To prevent proliferation rate recovery after palbociclib washout (Supplementary Fig. 8c), we maintained palbociclib at 250 nM after treating the cells at 500 nM for the first 2 days (Supplementary Fig. 8e, f). By unpaired t-test, p = 0.0022 for c (n = 3); p = 0.0761 for d (n = 143 for −Pal, n = 56 for +Pal). e Schematics illustrating in vivo leukemogenesis by iMLL-AF9 GMPs. iMLL-AF9 GMPs were treated with palbociclib in vitro for 1 day (+/−Pal.) prior to their injection into sublethally irradiated recipient mice, which received three injections of palbociclib or vehicle control (+/−Pal.) on day 0, day 1, and day 2. All mice received 20,000 GMPs and were fed with Dox water. f Percentage of donor-derived cells (CD45.1/2) in the peripheral blood of recipient mice (CD45.2), assayed 7 weeks post transplantation; n = 5 for each group, p = 0.0156 by unpaired t-test. g Percentage of myeloid cells (Mac1+) in the peripheral blood of recipient mice, assayed 7 weeks post transplantation; n = 5 for each group, p = 0.0155 by unpaired t-test. h Kaplan–Meier curve of recipient mice developing AML after iMLL-AF9 GMP transplantations; n = 5 for each group, p = 0.0034 by Log-rank (Mantel–Cox) test. i Venn diagrams showing the Dox-induced DEGs when palbociclib was present (+Pal.) or not (−Pal.). j Dox-induced gene expression changes (Log2 fold change) in the absence or presence of palbociclib. The 765 commonly upregulated DEGs in i are shown in red, and the 1051 commonly downregulated DEGs in i are shown in blue. Each pair of dots denotes an individual gene and is connected by a line in +/−Pal. conditions. p < 0.0001 for both up and downregulated DEGs, p value was calculated by paired t-test. Results are presented as mean±s.d.
Fig. 6 Modification of the initial cell state by cell cycle inhibition mitigates MLL-AF9-mediated transformation. a Schematics illustrating the transformed colony formation by iMLL-AF9 GMPs +/−Pal. b Single-cell colony-forming assay showing colony forming efficiencies from iMLL-AF9 GMPs transiently treated with palbociclib. Each pair of dots connected by the line represent colony forming efficiencies of GMPs from a different iMLL-AF9 mouse; (n = 3), p = 0.0221 by paired t-test. c, d Quantification of colony number c and size d of bulk cultured iMLL-AF9 GMPs in methylcellulose +/−Pal. Dox was added to all conditions. To prevent proliferation rate recovery after palbociclib washout (Supplementary Fig. 8c), we maintained palbociclib at 250 nM after treating the cells at 500 nM for the first 2 days (Supplementary Fig. 8e, f). By unpaired t-test, p = 0.0022 for c (n = 3); p = 0.0761 for d (n = 143 for −Pal, n = 56 for +Pal). e Schematics illustrating in vivo leukemogenesis by iMLL-AF9 GMPs. iMLL-AF9 GMPs were treated with palbociclib in vitro for 1 day (+/−Pal.) prior to their injection into sublethally irradiated recipient mice, which received three injections of palbociclib or vehicle control (+/−Pal.) on day 0, day 1, and day 2. All mice received 20,000 GMPs and were fed with Dox water. f Percentage of donor-derived cells (CD45.1/2) in the peripheral blood of recipient mice (CD45.2), assayed 7 weeks post transplantation; n = 5 for each group, p = 0.0156 by unpaired t-test. g Percentage of myeloid cells (Mac1+) in the peripheral blood of recipient mice, assayed 7 weeks post transplantation; n = 5 for each group, p = 0.0155 by unpaired t-test. h Kaplan–Meier curve of recipient mice developing AML after iMLL-AF9 GMP transplantations; n = 5 for each group, p = 0.0034 by Log-rank (Mantel–Cox) test. i Venn diagrams showing the Dox-induced DEGs when palbociclib was present (+Pal.) or not (−Pal.). j Dox-induced gene expression changes (Log2 fold change) in the absence or presence of palbociclib. The 765 commonly upregulated DEGs in i are shown in red, and the 1051 commonly downregulated DEGs in i are shown in blue. Each pair of dots denotes an individual gene and is connected by a line in +/−Pal. conditions. p < 0.0001 for both up and downregulated DEGs, p value was calculated by paired t-test. Results are presented as mean±s.d.CC BY · PubMed Central
Fig. 7 Activated GMPs during emergency myelopoiesis support more efficient transformation. a Cell cycle rate distributions of steady-state control GMPs or 5FU-activated GMPs; n = 3 for Ctrl GMP, n = 2 for D8 5FU GMP. b Single-cell colony-forming efficiencies from steady-state control iMLL-AF9 GMPs or 5FU-activated iMLL-AF9 GMPs; n = 3 for Ctrl GMP, n = 2 for D8 5FU GMP. c Colony-forming efficiencies by 5FU-activated iMLL-AF9 GMPs of different cell cycle rates; n = 2, dotted line represents linear regression, y = 24.73 × +7.649, p = 0.0006 by F-test. d Schematics showing leukemogenesis by steady-state control iMLL-AF9 GMPs or 5FU-activated iMLL-AF9 GMPs. e Donor-derived (CD45.1+) nucleated cell percentages in peripheral blood of recipient mice at 4- or 6-weeks after transplantation; n = 6 for Ctrl GMP, n = 4 for D8 5FU GMP, p = 0.0027 for 4 weeks, p = 0.0243 for 6 weeks, as calculated by unpaired t-test. f Kaplan–Meier curve of the cohorts injected with steady-state control iMLL-AF9 GMPs or 5FU-activated iMLL-AF9 GMPs; n = 6 for Ctrl GMP, n = 4 for D8 5FU GMP, p = 0.0258 as calculated by Log-rank (Mantel–Cox) test. Results are presented as mean±s.d.
Fig. 7 Activated GMPs during emergency myelopoiesis support more efficient transformation. a Cell cycle rate distributions of steady-state control GMPs or 5FU-activated GMPs; n = 3 for Ctrl GMP, n = 2 for D8 5FU GMP. b Single-cell colony-forming efficiencies from steady-state control iMLL-AF9 GMPs or 5FU-activated iMLL-AF9 GMPs; n = 3 for Ctrl GMP, n = 2 for D8 5FU GMP. c Colony-forming efficiencies by 5FU-activated iMLL-AF9 GMPs of different cell cycle rates; n = 2, dotted line represents linear regression, y = 24.73 × +7.649, p = 0.0006 by F-test. d Schematics showing leukemogenesis by steady-state control iMLL-AF9 GMPs or 5FU-activated iMLL-AF9 GMPs. e Donor-derived (CD45.1+) nucleated cell percentages in peripheral blood of recipient mice at 4- or 6-weeks after transplantation; n = 6 for Ctrl GMP, n = 4 for D8 5FU GMP, p = 0.0027 for 4 weeks, p = 0.0243 for 6 weeks, as calculated by unpaired t-test. f Kaplan–Meier curve of the cohorts injected with steady-state control iMLL-AF9 GMPs or 5FU-activated iMLL-AF9 GMPs; n = 6 for Ctrl GMP, n = 4 for D8 5FU GMP, p = 0.0258 as calculated by Log-rank (Mantel–Cox) test. Results are presented as mean±s.d.CC BY · PubMed Central
Fig. 8 Ly6C−CD115lo GMPs are further enriched for MLL-AF9-mediated transformation. a Cell cycle rate distributions of the GMP subpopulations during 0–24 h of culture, in the absence of Dox (n = 2). b Cell cycle rate distributions of the GMP subpopulations during 24–48 h of culture, in the absence of Dox (n = 2). c Cell cycle rates of individual cell lineages during 48 h of culture. Number of divisions during 0–24 h of culture (x-axis) were plotted vs those of 24–48 h (y-axis). Dotted diagonal line denotes y = x. Pseudocolor denotes lineage density, with the highest observed density in each sample normalized to 100. One representative experiment was shown, n = 161 for Ly6C−CD115lo, n = 168 for Ly6C + CD115lo, n = 180 for Ly6C + CD115hi. d Quantifications of the proportion of accelerating/constant/decelerating lineages within each GMP subset (n = 2). e RT-QPCR results showing the expression levels of Cdk4 and Cdk6 in FACS-sorted GMP subpopulations based on Ly6C and CD115 (n = 3). f Expression levels of Irf8 and Cebpe in fresh GMPs from scRNA-seq. Green dots denote the Ly6c2loCsf1rlo GMPs; orange dots denote the others. x-axis represents EES, with the higher EES values indicating more similar gene expression to Ly6c2loCsf1rlo GMPs. g Illustration of cell cycle rate dynamics during GMP differentiation. h Transformed colony-forming efficiencies by each subset of GMPs of different cycling rates (n = 2). All cells were cultured in the presence of Dox. Dotted lines represent linear regressions, for Ly6C−CD115lo, y = 22.20 × +36.02, p = 0.0032; for Ly6C + CD115lo, y = 21.09 × +6.380, p = 0.0004; for Ly6C + CD115hi, y = 15.80 × +1.933, p < 0.0001. p value was calculated by F-test to assess whether the slope is significantly nonzero. Results are presented as mean±s.d.
Fig. 8 Ly6C−CD115lo GMPs are further enriched for MLL-AF9-mediated transformation. a Cell cycle rate distributions of the GMP subpopulations during 0–24 h of culture, in the absence of Dox (n = 2). b Cell cycle rate distributions of the GMP subpopulations during 24–48 h of culture, in the absence of Dox (n = 2). c Cell cycle rates of individual cell lineages during 48 h of culture. Number of divisions during 0–24 h of culture (x-axis) were plotted vs those of 24–48 h (y-axis). Dotted diagonal line denotes y = x. Pseudocolor denotes lineage density, with the highest observed density in each sample normalized to 100. One representative experiment was shown, n = 161 for Ly6C−CD115lo, n = 168 for Ly6C + CD115lo, n = 180 for Ly6C + CD115hi. d Quantifications of the proportion of accelerating/constant/decelerating lineages within each GMP subset (n = 2). e RT-QPCR results showing the expression levels of Cdk4 and Cdk6 in FACS-sorted GMP subpopulations based on Ly6C and CD115 (n = 3). f Expression levels of Irf8 and Cebpe in fresh GMPs from scRNA-seq. Green dots denote the Ly6c2loCsf1rlo GMPs; orange dots denote the others. x-axis represents EES, with the higher EES values indicating more similar gene expression to Ly6c2loCsf1rlo GMPs. g Illustration of cell cycle rate dynamics during GMP differentiation. h Transformed colony-forming efficiencies by each subset of GMPs of different cycling rates (n = 2). All cells were cultured in the presence of Dox. Dotted lines represent linear regressions, for Ly6C−CD115lo, y = 22.20 × +36.02, p = 0.0032; for Ly6C + CD115lo, y = 21.09 × +6.380, p = 0.0004; for Ly6C + CD115hi, y = 15.80 × +1.933, p < 0.0001. p value was calculated by F-test to assess whether the slope is significantly nonzero. Results are presented as mean±s.d.CC BY · PubMed Central
Fig. 9 CCND1 expression level stratifies MLL translocation leukemia patient survival. a Expression levels of HOXA9, CDK6, and CCND1/2/3 in human GMP subsets. RNA-seq data from GSE96811 were plotted35. Error bars represent s.d. b Overall survival of MLL leukemia patients. Patient data were downloaded from TARGET-AML datasets, and only patients with available RNA-seq data were included in the analysis. 30 MLL leukemia patients were divided into two groups according to their CCND1 expression level. 15 patients with CCND1 level higher than median were grouped as CCND1 High, 15 patients with CCND1 level lower than median were grouped as CCND1 Low, p = 0.0314, by Log-rank (Mantel–Cox) test. c Overall survivals of nonMLL leukemia patients. Same analysis as described in b was performed in nonMLL leukemia patients; n = 72 for CCND1 High group, n = 71 for CCND1 Low group, p = 0.4869 by Log-rank (Mantel–Cox) test.
Fig. 9 CCND1 expression level stratifies MLL translocation leukemia patient survival. a Expression levels of HOXA9, CDK6, and CCND1/2/3 in human GMP subsets. RNA-seq data from GSE96811 were plotted35. Error bars represent s.d. b Overall survival of MLL leukemia patients. Patient data were downloaded from TARGET-AML datasets, and only patients with available RNA-seq data were included in the analysis. 30 MLL leukemia patients were divided into two groups according to their CCND1 expression level. 15 patients with CCND1 level higher than median were grouped as CCND1 High, 15 patients with CCND1 level lower than median were grouped as CCND1 Low, p = 0.0314, by Log-rank (Mantel–Cox) test. c Overall survivals of nonMLL leukemia patients. Same analysis as described in b was performed in nonMLL leukemia patients; n = 72 for CCND1 High group, n = 71 for CCND1 Low group, p = 0.4869 by Log-rank (Mantel–Cox) test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Burkhardt D. B., et al. Quantifying the effect of experimental perturbations in single-cell RNA-sequencing data using graph signal processing. Preprint at https://doi.org/10.1101/532846v2 (2019). · doi:10.1101/532846v2

Cited by

See all 59

Metadata

Authors
Chen, X., Burkhardt, D. B., Hartman, A. A., Hu, X., Eastman, A. E., Sun, C., Wang, X., Zhong, M., Krishnaswamy, S., & Guo, S.
Affiliations
  • Yale University (US)
  • Shanghai Jiao Tong University (CN)
Corresponding author
Guo, Shangqin
Venue
Nature Communications
Published
2019-12-18
Volume
10
Issue
1
Pages
5767-5767
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2994659459
Cited by
58
References
53
Citations by year
2025: 5 · 2024: 8 · 2023: 10 · 2022: 12 · 2021: 16 · 2020: 6 · 2019: 1
FWCI
6.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (DP2GM123507)
  • Gilead Sciences
  • Charles H. Hood Foundation
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
MLL-AF9, acute myeloid leukemia, cell of origin, myeloid progenitor cells, CFU-GM, cell cycle heterogeneity, CCND1, prognosis, leukemia prevention
MeSH terms
Animals, Cell Cycle, Cell Differentiation, Cell Transformation, Neoplastic, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Piperazines, Prognosis, Pyridines, Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, Gene Expression Regulation, Leukemic, Cyclin D1, Myeloid Progenitor Cells, Cell Proliferation, Myeloid-Lymphoid Leukemia Protein, Kaplan-Meier Estimate, Gene Knock-In Techniques, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors. https://app.cochat.ai/papers/10.1038/s41467-019-13666-5
The paper
Chen, X., Burkhardt, D. B., Hartman, A. A., Hu, X., Eastman, A. E., Sun, C., Wang, X., Zhong, M., Krishnaswamy, S., & Guo, S. (2019). MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors. Nature Communications. https://doi.org/10.1038/s41467-019-13666-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.